Liquid Biopsy Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors Of Liquid Biopsy Market
The liquid biopsy market size was valued at USD 8.01 billion in 2023, and the market is now projected to grow from USD 9.63 billion in 2024 to USD 58.64 billion by 2032, exhibiting a CAGR of 25.3% during the forecast period of 2024-2032.
The impact of the COVID-19 pandemic ended in a decline in marketplace boom in 2020. Non-critical diagnostic checks, including most cancers screening, had been postponed and deprioritized by means of healthcare organizations. Additionally, disruptions to global deliver chains caused shortages of most cancers diagnostic kits and assays globally at some point of the pandemic.
Recent advancements in liquid biopsies have enabled new technology for most cancers screening, healing selection, drug trial optimization, and recurrence monitoring. Major groups are closely making an investment in R&D to behavior clinical research on liquid biopsy, aiming to offer precision medicinal drug to fulfill the growing most cancers occurrence and the growing adoption of liquid biopsies amongst patients.
Liquid biopsy is rising as a singular, non-invasive technique for detecting and tracking cancer in numerous frame fluids rather than tumor tissue. These checks offer an opportunity for patients not able to go through an invasive biopsy for screening, even as additionally providing medical programs such as sickness diagnosis, drug resistance, and drug reaction evaluation.
Comprehensive Analysis Of Liquid Biopsy Market
The liquid biopsy market growth is rising at an exponential rate due to its market segmentation. This marketplace enlargement successfully affords an in-depth local exam thinking about the dominant deliver and demand forces that effect the enterprise. These segmentations are methodically segregated by product analysis, by application analysis, by end user analysis. By product analysis include, kits & reagents and instruments. By application analysis include Non-Invasive Prenatal Testing (NIPT), oncology, and others. By end user analysis include, hospitals, clinical laboratories, and others.
The North America region lead the liquid biopsy market share by benefitting a market size of USD 4.36 billion in 2023 due to rising R&D and introduction of new technologies via key gamers to assist aid in patient screening for persistent problems or abnormalities.
The pinnacle players inside the market play a critical function in the enterprise assuring market growth and placing marketplace requirements. These players include, Guardant Health, Personalis, Inc., Foundation Medicine, Inc., Natera, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd, Menarini Silicon Biosystems, Inc., Thermo Fisher Scientific Inc., QIAGEN, and Bio-Rad Laboratories, Inc. These market players provide a level-playing competitive landscape.
In February 2024, Twist Bioscience Corporation brought a cfDNA library instruction package to aid liquid biopsy studies.
Segmentation Table
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth RateCAGR of 25.3% from 2024-2032
Unit Value (USD Billion)
Segmentation By Product
Kits & Reagents
Instruments
By Application
Non-invasive Prenatal Testing (NIPT)
Oncology
Others
By End User
Hospitals
Clinical Laboratories
Others
By Region
North America (By Product, By Application, By End User, and By Country)
U.S. (By Application)
Canada (By Application)
Europe (By Product, By Application, By End User, and By Country/ Sub-region)
Germany (By Application)
U.K. (By Application)
France (By Application)
Italy (By Application)
Spain (By Application)
Rest of Europe ((By Application)
Asia Pacific (By Product, By Application, By End User, and By Country/ Sub-region)
Japan (By Application)
China (By Application)
India (By Application)
Australia (By Application)
Southeast Asia (By Application)
Rest of Asia Pacific (By Application)
Latin America (By Product, By Application, By End User, and By Country/ Sub-region)
Brazil (By Application)
Mexico (By Application)
Rest of Latin America (By Application)
Middle East & Africa (By Product, By Application, By End User, and By Country/ Sub-region)
GCC (By Application)
South Africa (By Application)
Rest of Middle East & Africa (By Application)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Cancer, By Key Countries, 2023
- 4.2. Key Industry Developments - Mergers, Partnerships, & Acquisitions
- 4.3. New Product Launches, By Key Players
- 4.4. Impact of COVID-19 on the Market
- 5. Global Liquid Biopsy Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Product
- 5.1.1. Kits & Reagents
- 5.1.2. Instruments
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Non-invasive Prenatal Testing (NIPT)
- 5.2.2. Oncology
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast – By End User
- 5.3.1. Hospitals
- 5.3.2. Clinical Laboratories
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East and Africa
- 6. North America Liquid Biopsy Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Product
- 6.1.1. Kits & Reagents
- 6.1.2. Instruments
- 6.2. Market Analysis, Insights and Forecast – By Application
- 6.2.1. Non-invasive Prenatal Testing (NIPT)
- 6.2.2. Oncology
- 6.2.3. Others
- 6.3. Market Analysis, Insights and Forecast – By End User
- 6.3.1. Hospitals
- 6.3.2. Clinical Laboratories
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.1.1. By Application
- 6.4.2. Canada
- 6.4.2.1. By Application
- 7. Europe Liquid Biopsy Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Product
- 7.1.1. Kits & Reagents
- 7.1.2. Instruments
- 7.2. Market Analysis, Insights and Forecast – By Application
- 7.2.1. Non-invasive Prenatal Testing (NIPT)
- 7.2.2. Oncology
- 7.2.3. Others
- 7.3. Market Analysis, Insights and Forecast – By End User
- 7.3.1. Hospitals
- 7.3.2. Clinical Laboratories
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 7.4.1. U.K.
- 7.4.1.1. By Application
- 7.4.2. Germany
- 7.4.2.1. By Application
- 7.4.3. France
- 7.4.3.1. By Application
- 7.4.4. Spain
- 7.4.4.1. By Application
- 7.4.5. Italy
- 7.4.5.1. By Application
- 7.4.6. Rest of Europe
- 7.4.6.1. By Application
- 8. Asia Pacific Liquid Biopsy Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Product
- 8.1.1. Kits & Reagents
- 8.1.2. Instruments
- 8.2. Market Analysis, Insights and Forecast – By Application
- 8.2.1. Non-invasive Prenatal Testing (NIPT)
- 8.2.2. Oncology
- 8.2.3. Others
- 8.3. Market Analysis, Insights and Forecast – By End User
- 8.3.1. Hospitals
- 8.3.2. Clinical Laboratories
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 8.4.1. Japan
- 8.4.1.1. By Application
- 8.4.2. China
- 8.4.2.1. By Application
- 8.4.3. India
- 8.4.3.1. By Application
- 8.4.4. Australia
- 8.4.4.1. By Application
- 8.4.5. Southeast Asia
- 8.4.5.1. By Application
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Application
- 9. Latin America Liquid Biopsy Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Product
- 9.1.1. Kits & Reagents
- 9.1.2. Instruments
- 9.2. Market Analysis, Insights and Forecast – By Application
- 9.2.1. Non-invasive Prenatal Testing (NIPT)
- 9.2.2. Oncology
- 9.2.3. Others
- 9.3. Market Analysis, Insights and Forecast – By End User
- 9.3.1. Hospitals
- 9.3.2. Clinical Laboratories
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Application
- 9.4.2. Mexico
- 9.4.2.1. By Application
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Application
- 10. Middle East & Africa Liquid Biopsy Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast – By Product
- 10.1.1. Kits & Reagents
- 10.1.2. Instruments
- 10.2. Market Analysis, Insights and Forecast – By Application
- 10.2.1. Non-invasive Prenatal Testing (NIPT)
- 10.2.2. Oncology
- 10.2.3. Others
- 10.3. Market Analysis, Insights and Forecast – By End User
- 10.3.1. Hospitals
- 10.3.2. Clinical Laboratories
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 10.4.1. GCC
- 10.4.1.1. By Application
- 10.4.2. South Africa
- 10.4.2.1. By Application
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Application
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2023)
- 11.2. Company Profiles
- 11.2.1. Guardant Health
- 11.2.1.1. Overview
- 11.2.1.2. Products & Services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. PERSONALIS, INC.
- 11.2.2.1. Overview
- 11.2.2.2. Products & Services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. FOUNDATION MEDICINE, INC.
- 11.2.3.1. Overview
- 11.2.3.2. Products & Services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Natera, Inc.
- 11.2.4.1. Overview
- 11.2.4.2. Products & Services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Illumina, Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products & Services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. F. Hoffmann-La Roche Ltd
- 11.2.6.1. Overview
- 11.2.6.2. Products & Services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Menarini Silicon Biosystems, Inc.
- 11.2.7.1. Overview
- 11.2.7.2. Products & Services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Thermo Fisher Scientific Inc.
- 11.2.8.1. Overview
- 11.2.8.2. Products & Services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. QIAGEN
- 11.2.9.1. Overview
- 11.2.9.2. Products & Services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Bio-Rad Laboratories, Inc.
- 11.2.10.1. Overview
- 11.2.10.2. Products & Services
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook